Literature DB >> 20499310

Immortalization of oral keratinocytes by functional inactivation of the p53 and pRb pathways.

Serge J Smeets1, Marlon van der Plas, Tieneke B M Schaaij-Visser, Eva A M van Veen, Johan van Meerloo, Boudewijn J M Braakhuis, Renske D M Steenbergen, Ruud H Brakenhoff.   

Abstract

A subgroup of head and neck squamous cell carcinomas (HNSCCs) contains high-risk human papillomavirus-type 16 (HPV16). The viral E6 and E7 oncoproteins inactivate the p53 and pRb proteins, respectively. We examined the causative effect of HPV16 E6 and E7 expression on the immortalization of normal oral keratinocytes (OKCs) and compared the resulting phenotype with alternative ways of p53- and pRb-pathway abrogation frequently found in HNSCCs without HPV. Primary OKCs were conditionally immortalized with temperature-sensitive SV40 large T-antigen and human telomerase, allowing these cells to return to their senescent primary state after temperature shift. HPV16 E6 and E7 were introduced to overcome senescence, determined with population doubling (PD) as read-out. For comparison, we downregulated p53 and p16 by short hairpin RNA genes and expressed mutant p53R(175)H and cyclinD1. Expression of HPV16 E6 caused an extended life span similar to expression of mutant p53R(175)H or p53 knockdown. Expression of mutant p53R(175)H seemed to cause additional activation of the hypoxia and WNT signaling pathways. HPV16 E7 expression had no direct effect on lifespan, similar to p16 knockdown or cyclinD1 expression. In combination with HPV16 E6 or other functional inactivations of p53, abrogation of the pRb-pathway by either HPV16 E7 or other manipulations caused an immortal phenotype. Our data show the causative role of HPV16 E6/E7 in early squamous carcinogenesis. Activity of each gene could be mimicked by other genetic events frequently found in HNSCC without HPV. This data provides the experimental proof of causal association of HPV in HNSCC carcinogenesis and further support the crucial role of the p53- and pRb-pathways.
Copyright © 2010 UICC.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20499310     DOI: 10.1002/ijc.25474

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  33 in total

1.  Establishment of shrimp cell lines: perception and orientation.

Authors:  P Jayesh; Jose Seena; I S Bright Singh
Journal:  Indian J Virol       Date:  2012-08-14

Review 2.  The molecular landscape of head and neck cancer.

Authors:  C René Leemans; Peter J F Snijders; Ruud H Brakenhoff
Journal:  Nat Rev Cancer       Date:  2018-03-02       Impact factor: 60.716

Review 3.  Biology of human papillomavirus-related oropharyngeal cancer.

Authors:  Jason D Howard; Christine H Chung
Journal:  Semin Radiat Oncol       Date:  2012-07       Impact factor: 5.934

4.  Identification of prognostic molecular biomarkers in 157 HPV-positive and HPV-negative squamous cell carcinomas of the oropharynx.

Authors:  Snjezana Dogan; Bin Xu; Sumit Middha; Chad M Vanderbilt; Anita S Bowman; Jocelyn Migliacci; Luc G T Morris; Venkatraman E Seshan; Ian Ganly
Journal:  Int J Cancer       Date:  2019-05-30       Impact factor: 7.396

Review 5.  Treatment de-intensification strategies for head and neck cancer.

Authors:  Jacqueline R Kelly; Zain A Husain; Barbara Burtness
Journal:  Eur J Cancer       Date:  2016-10-15       Impact factor: 9.162

6.  Human Papillomavirus and Oropharyngeal Squamous Cell Carcinoma of the Head and Neck: A Growing Epidemic.

Authors:  Jessica Bauman; Lori Wirth
Journal:  Adolesc Med State Art Rev       Date:  2014-08

7.  Intranodal cystic changes: a potential radiologic signature/biomarker to assess the human papillomavirus status of cases with oropharyngeal malignancies.

Authors:  Ajaykumar C Morani; Avraham Eisbruch; Thomas E Carey; Samantha J Hauff; Heather M Walline; Suresh K Mukherji
Journal:  J Comput Assist Tomogr       Date:  2013 May-Jun       Impact factor: 1.826

Review 8.  Human papillomavirus-associated oropharynx cancer (HPV-OPC): treatment options.

Authors:  Nicole G Chau; Guilherme Rabinowits; Robert I Haddad
Journal:  Curr Treat Options Oncol       Date:  2014-12

Review 9.  Oropharyngeal squamous cell carcinoma treatment: current standards and future directions.

Authors:  Shanthi Marur; Barbara Burtness
Journal:  Curr Opin Oncol       Date:  2014-05       Impact factor: 3.645

Review 10.  Oncoapoptotic markers in oral cancer: prognostics and therapeutic perspective.

Authors:  Anubhav Jain; Saurabh Bundela; Ram P Tiwari; Prakash S Bisen
Journal:  Mol Diagn Ther       Date:  2014-10       Impact factor: 4.074

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.